TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 3.02%-16.46M | ---- | -82.50%-16.97M | ---- | -193.46%-9.3M | ---- | -61.69%9.95M | ---- | -18.34%25.97M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -103.98%-231.06K | ---- | 79.33%-113.28K | ---- | 58.81%-548.04K | ---- | 11.55%-1.33M | ---- | -464.91%-1.5M |
Interest expense - adjustment | ---- | -34.52%1.41M | ---- | -9.33%2.15M | ---- | -35.86%2.38M | ---- | -44.24%3.7M | ---- | -64.85%6.64M |
Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 6.59%-984.13K | ---- | -29.96%-1.05M |
Attributable subsidiary (profit) loss | ---- | 56.02%760.71K | ---- | --487.56K | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | -86.28%1.58M | ---- | -18.50%11.5M | ---- | 117.28%14.11M | ---- | -5.39%6.49M | ---- | 173.43%6.86M |
-Other impairments and provisions | ---- | -86.28%1.58M | ---- | -18.50%11.5M | ---- | 117.28%14.11M | ---- | -5.39%6.49M | ---- | 173.43%6.86M |
Revaluation surplus: | ---- | -209.69%-223.08K | ---- | -91.28%203.37K | ---- | 231.08%2.33M | ---- | -794.64%-1.78M | ---- | --256.09K |
-Other fair value changes | ---- | -209.69%-223.08K | ---- | -91.28%203.37K | ---- | 231.08%2.33M | ---- | -794.64%-1.78M | ---- | --256.09K |
Asset sale loss (gain): | ---- | -5,894.16%-2.49M | ---- | 13.10%-41.49K | ---- | ---47.74K | ---- | ---- | ---- | --1.09K |
-Loss (gain) from sale of subsidiary company | ---- | ---2.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 127.37%11.36K | ---- | 13.10%-41.49K | ---- | ---47.74K | ---- | ---- | ---- | --1.09K |
Depreciation and amortization: | ---- | 14.50%6.06M | ---- | 377.18%5.29M | ---- | -2.62%1.11M | ---- | 2.99%1.14M | ---- | 849.11%1.11M |
-Depreciation | ---- | 14.68%5.97M | ---- | 410.62%5.2M | ---- | -2.85%1.02M | ---- | 1.49%1.05M | ---- | 1,317.31%1.03M |
-Other depreciation and amortization | ---- | 4.23%94.2K | ---- | 0.00%90.38K | ---- | 0.00%90.38K | ---- | 24.32%90.38K | ---- | 66.61%72.7K |
Operating profit before the change of operating capital | ---- | -481.86%-9.59M | ---- | -74.96%2.51M | ---- | -41.66%10.03M | ---- | -55.09%17.19M | ---- | -26.74%38.28M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 62.23%-4.31M | ---- | -1,242.55%-11.42M | ---- | ---850.44K | ---- | ---- | ---- | ---- |
Accounts receivable (increase)decrease | ---- | -111.40%-2.95M | ---- | -12.19%25.83M | ---- | -61.00%29.41M | ---- | -66.62%75.41M | ---- | 21.94%225.94M |
Special items for working capital changes | ---- | -106.47%-3.7M | ---- | 238.46%57.26M | ---- | 139.39%16.92M | ---- | 74.53%-42.95M | ---- | -836.58%-168.59M |
Cash from business operations | 67.22%-23.22M | -127.70%-20.55M | -235.32%-70.83M | 33.63%74.18M | -259.32%-21.12M | 11.78%55.51M | 262.44%13.26M | -48.07%49.66M | 6.75%-8.16M | -56.44%95.63M |
Other taxs | 2,021.65%760.03K | 75.08%-710.21K | 98.20%-39.55K | 36.36%-2.85M | 32.22%-2.2M | 37.05%-4.48M | 49.90%-3.24M | -19.23%-7.11M | -30.25%-6.47M | 37.92%-5.97M |
Net cash from operations | 68.31%-22.46M | -129.81%-21.26M | -203.89%-70.86M | 39.78%71.33M | -332.84%-23.32M | 19.95%51.03M | 168.44%10.02M | -52.55%42.54M | -6.65%-14.63M | -57.29%89.67M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -65.53%50.09K | 103.98%231.06K | 68.21%145.33K | -37.49%113.28K | -8.70%86.4K | -48.25%181.2K | -29.66%94.64K | 55.82%350.12K | -25.76%134.55K | -15.62%224.7K |
Loan receivable (increase) decrease | ---- | ---- | ---- | --0 | 3.61%-8M | -62.59%366.84K | -987.37%-8.3M | -23.38%980.49K | 102.93%935.35K | 142.81%1.28M |
Sale of fixed assets | --18.96K | --3.31K | ---- | ---- | ---- | 31,256.50%62.71K | --60.87K | -93.57%200 | ---- | --3.11K |
Purchase of fixed assets | -1,098.14%-18.14M | 85.47%-4.29M | 94.17%-1.51M | 36.64%-29.49M | -6.77%-25.97M | -115.09%-46.55M | -642.80%-24.33M | -20,392.67%-21.64M | -51,717.45%-3.27M | 76.48%-105.62K |
Purchase of intangible assets | ---- | ---130.9K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,212.69%-424.37K |
Sale of subsidiaries | ---- | --6.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | 305.95%59.32M | -69.20%60.46M | -90.89%14.61M | -37.80%196.28M | -5.59%160.45M | -37.11%315.59M | -59.49%169.95M | -37.28%501.84M | 57,247.41%419.47M | 61.71%800.14M |
Cash on investment | ---30.86M | 60.76%-73.89M | ---- | 38.66%-188.3M | -2.37%-142.8M | 41.71%-306.98M | 67.02%-139.5M | 36.04%-526.63M | ---422.97M | -66.68%-823.36M |
Other items in the investment business | ---- | ---- | ---- | -89.97%223.62K | ---- | --2.23M | ---- | ---- | ---- | ---- |
Net cash from investment operations | -21.59%10.38M | 46.34%-11.36M | 181.56%13.24M | 39.67%-21.17M | -701.79%-16.24M | 22.20%-35.1M | 64.53%-2.03M | -102.86%-45.11M | 81.82%-5.71M | -2,080.88%-22.24M |
Net cash before financing | 79.05%-12.07M | -165.04%-32.62M | -45.67%-57.62M | 214.79%50.15M | -595.06%-39.56M | 720.61%15.93M | 139.28%7.99M | -103.81%-2.57M | 54.91%-20.34M | -68.05%67.43M |
Cash flow from financing activities | ||||||||||
New borrowing | --10M | -84.22%10M | ---- | 50.52%63.36M | 3.01%43.36M | -58.72%42.09M | -58.72%42.09M | 20.82%101.97M | 239.90%101.97M | -69.31%84.4M |
Refund | 89.89%-1M | 47.59%-31.74M | 36.97%-9.89M | -1.36%-60.56M | 64.93%-15.69M | 57.91%-59.75M | 46.41%-44.75M | 27.81%-141.97M | -73.98%-83.51M | 56.30%-196.67M |
Interest paid - financing | 57.41%-312.71K | 32.77%-1.45M | 22.81%-734.16K | 9.94%-2.15M | 2.69%-951.07K | 34.39%-2.39M | 40.23%-977.35K | 43.12%-3.65M | 59.35%-1.64M | 62.28%-6.41M |
Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---4.48M | ---- | ---- | ---- | ---4.99M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | --2.25M | --2.25M | ---- | ---- | ---- |
Other items of the financing business | ---- | ---- | --163.39K | --848.61K | ---- | ---- | ---- | -94.25%1.73M | ---- | 4,821.67%30M |
Net cash from financing operations | 178.10%8.41M | -2,433.83%-23.8M | -140.74%-10.77M | 104.42%1.02M | 1,567.06%26.43M | 46.11%-23.07M | -111.00%-1.8M | 54.71%-42.81M | 173.12%16.38M | 24.57%-94.52M |
Effect of rate | 17.95%-18.97K | 87.99%-26.32K | 85.58%-23.11K | -663.42%-219.07K | -884.44%-160.33K | -87.94%38.88K | 123.38%20.44K | 249.76%322.4K | 36.24%-87.43K | -112.86%-215.27K |
Net Cash | 94.64%-3.66M | -210.26%-56.43M | -420.86%-68.39M | 816.94%51.17M | -312.15%-13.13M | 84.27%-7.14M | 256.25%6.19M | -67.51%-45.38M | 94.13%-3.96M | -131.59%-27.09M |
Begining period cash | -80.53%13.65M | 266.14%70.1M | 266.14%70.1M | -27.05%19.15M | -27.05%19.15M | -63.19%26.25M | -63.19%26.25M | -27.69%71.3M | -27.69%71.3M | 781.70%98.6M |
Cash at the end | 489.62%9.97M | -80.53%13.65M | -71.14%1.69M | 266.14%70.1M | -81.96%5.86M | -27.05%19.15M | -51.74%32.45M | -63.19%26.25M | 117.38%67.25M | -27.69%71.3M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.